ENO2 and squamous cell lung carcinoma: The results indicate no significant differences in NSE, cancer antigen 125 (CA-125), and CYFA21-1, but significantly higher expression of CEA in patients with adenocarcinoma lung cancer relative to those with squamous cell lung carcinoma (p = 0.002).